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Part II 
NITROGEN MUSTARD 
AS A TREATMENT FOR 
Canine Malignant Lymphoma 
E,lroy C. Jensen, D.V.M. 
A series of blood examinations follow: 
One day after treatment: 17 days after treatment: 28 days after treatment: 
Hemoglobin 
Red Blood Cells 
White Blood Cells 
Eosinophils 
Stabs 
Segments 
Monocytes 
Lymphocytes 
Sedimentation rate: 
50.1 (i~ or 7.26 Gm. 
4,460,000 
20,580 
200 
6,700 
11,400 
400 
2,300 
17 mm./hr. 
At the time of discharge, the owner was 
advised to give liver at least twice weekly 
as well as 1 Cebetinic (Upjohn) tablet 
daily. There was a decided remission of 
symptoms, but the blood picture was get-
ting less favorable all the time. Euthana-
sia was decided upon by the owner 1 
month after treatment. Post mortem 
findings revealed a generalized enlarge-
ment of the lymph nodes, spleen three 
times normal size with tumor infiltration 
in this organ as well as the liver, kidney 
and bone marrow. Anasarca was also 
present. 
Case # 3 
A 10 year-old, male, 48 pound, Irish 
Setter, was referred to this clinic by a 
neighboring veterinarian as a suspected 
malignant lymphoma. The dog was hav-
ing trouble breathing due to the size of 
the lymph nodes in the region of the tra-
The first part of Dr. Je~"1.sen's article appeared 
in I.S.C. Veterinarian Vol. XVIII, No.2. 
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52.3% or 7.58 Gm. 
4,330,000 
25,780 
100 
3,300 
18,380 
100 
2,900 
9 mm.!hr. 
44% or 6.38 Gm. 
3,890,000 
44,160 
400 
18,000 
18,860 
7,600 
13 mm./hr. 
chea and lungs. The dog was in the ter-
minal stage of the disease. Blood findings 
were as follows: 
Hemoglobin 
Red Blood Cells 
White Blood Cells 
Eosinophils 
Stabs 
Segments 
Monocytes 
Lymphocytes 
Sedimentation rate 
76.7% or 11.12 Gm. 
6,670,000 
13,820 
19 mm/hr 
100 
2,100 
10,600 
100 
1,000 
Thirty-three and six-tenths milligrams 
of L-cysteine were given prior to the in-
jection of 8.4 mg. (0.4 mg./kg.) of nitro-
gen mustard. A 4 day treatment was used. 
Four hundred micrograms of B12 were 
given on the last day of medication. 
There was slight improvement in the 
dog's condition during the course of 
treatment with some regression of the 
lymph nodes, but the dog died 2 days 
after being discharged. The owner did 
not return the dog for a post mortem ex-
amination. 
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Case # 4 
This was a 23 pound, 7-year-old, female, 
Scottish Terrier. All of the palpable 
lymph nodes were enlarged. Due to a 
lack of having the drug on hand, a delay 
of over 2 weeks occurred before the 
dog was treated. Three blood counts were 
taken· as indicated below: 
18 days prior to first 
treatment. 
Red Blood Cells 
White Blood Cells 
Stabs 
Segments 
Monocytes 
Eosinophils 
Lymphocytes 
23,600 
9,300 
7,200 
200 
2,100 
4,700 
At the time of the second blood count, 
the lymph nodes had increased consider-
ably. However, the dog's general condi-
tion appeared good. The course of treat-
ment consisted of 20 mg. of L-cysteine fol-
lowed by 3.8 mg. of nitrogen mustard for 
the first day, the last three doses being 
increased to 5.0 mg. (0.5 mg./kg.) of ni-
trogen mustard daily. The dosage of L-
cysteine was the same. At the end of 
therapy the lymph nodes had decreased 
by one-third. The dog was discharged on 
the last day of medication. Thirty-eight 
days later, a 3 day course of treatment 
was initiated using a daily dosage of 20 
mg. L-cysteine and 5 mg. nitrogen mus-
tard. The dog vomited on the second day. 
The second course of therapy was not as 
effective in causing a regression of the 
lymph nodes. Six weeks after the last 
course of therapy the dog died. The dog 
was not returned for a post mortem ex-
amination. 
Case # 5 
The patient was a 5-year-old, 44 pound, 
male, Dalmatian with a history of having 
enlargement of the superficial lymph 
nodes of two or more weeks duration. A 
blood count revealed the following: 
Hemoglobin 
Red Blood Cells 
White Blood Cells 
Stabs 
Segments 
Monocytes 
Lymphocytes 
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59.1 % or 8.57 Gm. 
6,050,000 
45,900 
9,600 
22,800 
400 
13,200 
A 4 day treatment of nitrogen mus-
tard was started. Forty milligrams of L-
cysteine followed by 5 mg. (0.25 mg./kg.) 
of Mustargen was the dosage used. The 
lymph nodes became progressively small-
er with each treatment. Four days later 
the dog was discharged. Five days follow-
ing discharge, the dog was returned to 
one day prior to first 38 days after first 
treatment. treatment. 
6,000,000 
27,600 
3,300 
9,600 
2,100 
12,600 
39,700 
15,500 
15,000 
1,500 
7,800 
the clinic as it hadn't eaten for several 
days. Two-hundred-fifty cc. of Dextrose 
and 50 cc. of Parenamine (Winthrop 
Stearns) was given subcutaneously and 
500 cc. whole blood 1. V. The fluid ther-
apy was continued the following day with 
the exception of the blood. A generalized 
jaundice was apparent. The dog died 2 
days after admission. Post mortem find-
ings were: liver one-third larger than 
normal with a slight cirrhosis and exten-
sive central lobular coagulation necrosis; 
the spleen was five times its normal size 
with multiple septic infarcts; multiple 
septic infarcts were present in the kid-
neys; most of the lymph nodes were con-
verted into abscesses containing a thin 
bloody exudate with the most extensive 
changes in the inguinal, iliac and submax-
illary; the cadaver was icteric; multiple 
petechial hemorrhages w ere found 
throughout the cadaver. Bacterial cult-
ures revealed Streptococcus canis septi-
cemia. Microscopic examination of the 
spleen and liver revealed the typical les-
ions of malignant lymphoma. Whether 
the Mustargen treatment lowered the re-
sistance of the dog to infection is a mat-
ter of conjecture. 
Case # 6 
A 3-year-old, male, 27 pound, Cocker 
Spaniel was brought to the clinic because 
of swellings around the throat region 
which the owner had noticed for the last 
2-3 days. All of the palpable lymph nodes 
Iowa State College Veterinarian 
were larger than normal. A biopsy of 
a lymph node was made and was diag-
nosed as malignant lymphoma. The dog 
appeared active and alert. A white blood 
cell count and differential were made. 
White Blood Cells 13,300 
Eosinophils 600 
Stabs 1,200 
Segments 1,800 
Monocytes 100 
Lymphocytes 2,900 
Our supply of Mustargen was ex-
hausted, so we told the owner we would 
call when our new supply arrived. Two 
weeks later the dog was given 24 mg. of L-
cysteine and 5.75 mg. (0.475) mg./ kg.) of 
nitrogen mustard daily for four doses. 
After the fourth treatment the lymph 
nodes had diminished greatly in size. The 
owner advised us by telephone that the 
dog had lived for approximately 4 months 
after the Mustargen treatment. She 
stated that the dog was quite depressed 
during the last few weeks of life. 
Discussion 
According to research work done at 
Merck & Co., the effects of Mustargen re-
semble in many ways those produced by 
total body exposure to x-rays. Also, the 
therapeutic results of its administration 
are nearly comparable to those of total 
body irradiation. The fact that tissues 
damaged by this drug appear to recover 
more rapidly than those with an equival-
ent injury from x-ray is also a marked ad-
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Malignant Lymphoma in a 
male cocker 51/2-years-old. 
upper left - spleen typically 
enlarged. 
lower left - kidney. 
right-m e sen tar i c lymph 
node attained 20 IDID. diame-
ter. Present at the root of the 
mesentary. 
vantage. Spurr, et a19 , speaking of the 
human, states nitrogen mustard can also 
be used in certain select cases of neo-
plasms where the condition has become 
roentgen resistant. Likewise, the drug 
could be used by those veterinary prac-
tioners who do not have x-ray therapy 
equipment available. 
In this report, two females and four 
males were represented. The breeds 
treated were: Cocker Spaniel 3, Irish 
Setter, Scottie and Dalmatian 1 each. The 
age incidence was 3-10 years with an 
average of 6.3 years. 
The dosage of Mustargen ranged from 
0.1 mg./ kg. to 0.5 mg. / kg. There was little 
information available on the exact dosage 
of this drug for treatment of neoplasms in 
the dog, so our dosage varied in an at-
tempt to find a satisfactory dosage as to 
tolerance by the animal and therapeutic 
effectiveness. From the few cases which 
we used the larger doses, it is doubtful 
whether the greater amount was much 
more effective than a dosage 0.1-0.2. mg./ 
kg. Besides, increased quantity of Mus-
targen administered requires daily blood 
counts as the margin of safety with a 
drug of this sort is very small. A very 
serious leukopenia could occur. Rather 
than start with a maximum dosage, it 
probably would be better to gradually 
increase the amount by 1 mg. per day as 
advised in the human. This would enable 
the clinician to better guard against se-
139 
rious consequences as a result of exces-
sive dosage. 
No "sloughs" were noted from the ad-
ministration of the drug to these six cases, 
although this may occur if the necessary 
precautions of administering are disre-
garded. 
L-cysteine was used in five of the six 
cases reported. In the case were it was 
not used (Case #2) a severe leukopenia 
was comparatively low 0.1 mg./kg. Suffic-
was comparatively low 0.1 mg/kg. Suffic-
ient blood examinations were not per-
formed to ascertain just how effective our 
dosage of 1-2 mg./kg. of L-cysteine was in 
preventing the severe leukopenia which 
usually results from a treatment of this 
sort. The administration of L-cysteine, as 
reported by Weisberger, et aI, and men-
tioned earlier in this report, also helps re-
duce nausea and vomiting. The only in-
cidence of vomiting which occurred 
among the six cases, occured in case # 4 
which vomited once during the second 
course of treatment. This occured on the 
second day of administration. The ap-
petite, however, appeared depressed dur-
ing the course of treatment in all of the 
cases mentioned. There was a marked im-
provement in the appetites following 
treatment in all of the cases except # 3 
& 5. Since this is merely a palliative treat-
ment, the apparent improvement in ap-
petite and well being of the dog may only 
last for a short time. 
Cases # 3 & 5 showed no improvement 
to the Mustargen treatment. These two 
dogs were in the terminal stages of the 
disease. The remaining four cases had re-
mission of symptoms with decrease in 
size of lymph nodes and improved general 
condition varying from 3-16 weeks. It was 
believed that this was definitely an ex-
tension of the dog's life over that which it 
would have lived should no treatment 
have been attempted. 
Specific therapy, however, is only as-
pect of the therapy necessary for treating 
malignant lymphoma. Blood transfusions 
are an invaluable aid in combating the 
anemia which is associated with this dis-
ease. The use of liver extracts, B 12, and 
other hematinics are indicated. The use of 
140 
antibiotics should be employed whenever 
there is any evidence of a serious infec-
tion complicating the disease. 
Summary 
1. Six cases of generalized malignant 
lymphoma in the dog were treated 
with nitrogen mustard (Mustargen). 
2. The two extremely advanced cases 
were not benefited by the use of this 
drug. 
3. Four cases in which the disease had 
been treated at an earlier stage had 
remissions of symptoms varying from 
3-16 weeks. 
4. Nitrogen mustard may be used in se-
lected cases of malignant lymphoma in 
the dog as a palliative treatment to 
prolong the animal's life. 
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